PTAB Invalidates Fresenius’ Patent on General Anesthetic Propofol

The PTO’s Patent Trial and Appeal Board invalidated several claims relating to the manufacture of the widely used anesthetic Diprivan (propofol), in a patent held by Fresenius Kabi.
Source: Drug Industry Daily